483
Lovelace Biomedical Research InstituteFDA 483 - Lovelace Biomedical Research Institute - January 27, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Lovelace Biomedical Research Institute in Albuquerque, NM, a GLP Laboratory Facility, revealed two significant issues. The facility failed to retain all raw data generated from nonclinical laboratory studies and did not assure that challenge agents were appropriately tested for identity. These observations indicate deficiencies in data integrity and quality control practices.
Open in Dashboard
ID · 06275513-06c6-4093-ab6e-d49bde789606